GGrantIndex
← Leaderboards

Lynn C. Hartmann

Mayo Clinic Coll Of Medicine, Rochester

$11,627,700
Attributed
$14,587,806
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.5M · FY200513
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$21,372,806 · 6

By mechanism

P50$9,163,782 · 3
K12$8,279,986 · 1
R01$3,929,038 · 2

Top collaborators

Most similar at Mayo Clinic Coll Of Medicine, Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Clinic

Research focus

ClinicResearch PersonnelProgramsMalignant NeoplasmsGrantBaseWomanCommunitiesSamplingInstructionPhenotypeOvarianMalignant Neoplasm Of OvaryMalignant Breast NeoplasmBreastMayo Clinic Cancer CenterNovel TherapeuticsNational Cancer InstituteTranslationsBiologyDesignBasic ScienceClinical TrialsPerformance

Grant awards (32)

Mechanisms of Immune Suppression in Ovarian Cancer$209,136
P50 · FY2013 · CA
Administration Core$138,222
P50 · FY2013 · CA · contact PI
Risk Prediction for Breast Cancer: A Tissue-Based Strategy$555,452
R01 · FY2012 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$327,530
P50 · FY2012 · CA
Administration Core$234,806
P50 · FY2012 · CA · contact PI
Mayo Clinic SPORE in Ovarian Cancer$2,185,000
P50 · FY2011 · CA · contact PI
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,134,000
K12 · FY2011 · CA
Risk Prediction for Breast Cancer: A Tissue-Based Strategy$573,372
R01 · FY2011 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$264,989
P50 · FY2011 · CA
Administration Core$231,078
P50 · FY2011 · CA · contact PI
Mayo Clinic SPORE in Ovarian Cancer$2,300,000
P50 · FY2010 · CA · contact PI
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,075,932
K12 · FY2010 · CA · contact PI
Risk Prediction for Breast Cancer: A Tissue-Based Strategy$607,495
R01 · FY2010 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$279,645
P50 · FY2010 · CA
Administration Core$206,482
P50 · FY2010 · CA · contact PI
Mayo Clinic SPORE in Ovarian Cancer$2,300,000
P50 · FY2009 · CA · contact PI
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,070,823
K12 · FY2009 · CA · contact PI
Risk Prediction for Breast Cancer: A Tissue-Based Strategy$614,156
R01 · FY2009 · CA · contact PI
Mechanisms of Immune Suppression in Ovarian Cancer$279,974
P50 · FY2009 · CA
Administration Core$206,920
P50 · FY2009 · CA · contact PI
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,065,864
K12 · FY2008 · CA · contact PI
Risk Prediction for Breast Cancer: A Tissue-Based Strategy$620,705
R01 · FY2008 · CA · contact PI
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$665,657
K12 · FY2007 · CA · contact PI
Paul Calabresi Program in Clinical-Translational Research at Mayo Clinic$1,056,374
K12 · FY2006 · CA · contact PI
Mayo Clinical Oncology Research Training Program$501,552
K12 · FY2005 · CA
Mayo Clinical Oncology Research Training Program$455,904
K12 · FY2004 · CA
Mayo Clinical Oncology Research Training Program$501,552
K12 · FY2003 · CA
Mayo Clinical Oncology Research Training Program$501,552
K12 · FY2002 · CA
PROPHYLCTIC MASTECTOMY IN HEREDITARY BREAST CANCER$280,747
R01 · FY2002 · CA
PROPHYLCTIC MASTECTOMY IN HEREDITARY BREAST CANCER$322,580
R01 · FY2001 · CA
Mayo Clinical Oncology Research Training Program$250,776
K12 · FY2001 · CA
PROPHYLCTIC MASTECTOMY IN HEREDITARY BREAST CANCER$354,531
R01 · FY2000 · CA